Difficulty: Medium
Average Score: 83%
Practice
A 41-year-old woman with acute myelogenous leukemia is undergoing a weekly intravenous infusion of chemotherapeutic agents. Upon completion of each cycle, she develops severe nausea and vomiting. A pharmacologic agent is administered intravenously, which seems to decrease nausea in this patient. This agent might have a mechanism of action at which of the following receptors?
Correct answer
C
Rationale
The correct answer to this question is C) 5-HT3 receptors. Chemotherapy-induced nausea and vomiting (CINV) is a common side effect of many chemotherapeutic agents. 5-HT3 receptors are specifically targeted to alleviate this symptom because they are located both centrally in the chemoreceptor trigger zone and peripherally on vagal afferents in the gastrointestinal tract. By blocking these receptors, the pharmacologic agent can effectively reduce nausea and vomiting in the patient.
Option A) 5-HT1 receptors are not primarily involved in the pathophysiology of CINV. These receptors are more associated with vasoconstriction, modulation of neurotransmitter release, and other functions.
Option B) 5-HT2 receptors are also not the main target for treating CINV. They are involved in various physiological processes such as smooth muscle contraction and mood regulation.
Option D) Dopamine receptors are more closely related to the stimulation of the chemoreceptor trigger zone and are targeted in other types of antiemetic treatments, such as those used for postoperative nausea and vomiting.
In an educational context, understanding the mechanisms of action of different pharmacologic agents used in managing chemotherapy side effects is crucial for healthcare professionals involved in oncology care. By grasping the specific receptor targets and pathways involved in CINV, healthcare providers can tailor treatment plans to optimize patient comfort and quality of life during cancer therapy.
Option A) 5-HT1 receptors are not primarily involved in the pathophysiology of CINV. These receptors are more associated with vasoconstriction, modulation of neurotransmitter release, and other functions.
Option B) 5-HT2 receptors are also not the main target for treating CINV. They are involved in various physiological processes such as smooth muscle contraction and mood regulation.
Option D) Dopamine receptors are more closely related to the stimulation of the chemoreceptor trigger zone and are targeted in other types of antiemetic treatments, such as those used for postoperative nausea and vomiting.
In an educational context, understanding the mechanisms of action of different pharmacologic agents used in managing chemotherapy side effects is crucial for healthcare professionals involved in oncology care. By grasping the specific receptor targets and pathways involved in CINV, healthcare providers can tailor treatment plans to optimize patient comfort and quality of life during cancer therapy.